Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $5.30 USD
Change Today +0.06 / 1.15%
Volume 636.5K
As of 8:10 PM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Angelo William Lovallo Jr.

Principal Financial Officer, Principal Accounting Officer, Vice President of Finance and Treasurer, Progenics Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

49$581,847
As of Fiscal Year 2014

Background*

Mr. Angelo William Lovallo, Jr. has been Treasurer of Progenics Pharmaceuticals, Inc. since 2011. Mr. Lovallo has been the Principal Financial Officer and Principal Accounting Officer of Progenics Pharmaceuticals, Inc. since October 1, 2012 and serves as its Senior Executive Director. Before joining Progenics in 2008 as Senior Director, Financial Reporting, Mr. Lovallo held Vice President, Financial Reporting positions at MBIA Inc. from 2004 to 2008 and AllianceBernstein ...

Read Full Background

Corporate Headquarters*

777 Old Saw Mill River Road
Tarrytown, New York 10591

United States

Phone: 914-789-2800
Fax: 914-789-2817

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BBA
Hofstra University

Other Affiliations*

Annual Compensation*

Salary$288,963
Total Annual Compensation$288,963

Stock Options*

All Other Compensation$10,952
Exercisable Options45,041
Exercisable Options Value$58,286
Unexercisable Options88,134
Unexercisable Options Value$231,968
Total Value of Options$290,254
Total Number of Options133,175

Total Compensation*

Total Annual Cash Compensation$393,842
Total Short Term Compensation$288,963
Other Long Term Compensation$10,952
Total Calculated Compensation$581,847
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PGNX:US $5.30 USD +0.06

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
Raul R. Rodriguez Chief Executive Officer, President, Director and Member of Finance Committee
Rigel Pharmaceuticals, Inc.
$551.7K
Steven W. King Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc
Peregrine Pharmaceuticals, Inc.
$557.7K
Daniel J. O'Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
$398.8K
William D. Clark Chief Executive Officer, President and Director
Genocea Biosciences, Inc.
$393.6K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROGENICS PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.